TRVI - CIK 0001563880
Trevi Therapeutics, Inc. has filed 524 documents with the SEC between 2012 and 2026. The most frequent type is insider trade (192 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13D/A | - | 2026-05-07 | - |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Quarterly report | 10-Q | 2026-05-05 | 2026-03-31 |
| Major company event | 8-K | 2026-05-05 | 2026-05-05 |
| Proxy statement | DEF 14A | 2026-04-21 | 2026-04-21 |
| Annual report to shareholders | ARS | 2026-04-21 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Prospectus supplement | 424B5 | 2026-04-17 | - |
| Major company event | 8-K | 2026-04-17 | 2026-04-16 |
| Prospectus supplement | 424B5 | 2026-04-16 | - |
| PRE 14A | - | 2026-04-10 | 2026-04-10 |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| Annual report | 10-K | 2026-03-17 | 2025-12-31 |
| Major company event | 8-K | 2026-03-17 | 2026-03-17 |
| Major company event | 8-K | 2026-03-09 | 2026-03-09 |
| Insider trade | 4 | 2026-02-20 | 2026-02-19 |
| Insider trade | 4 | 2026-02-20 | 2026-02-19 |
| Insider trade | 4 | 2026-02-20 | 2026-02-19 |
| Insider trade | 4 | 2026-02-20 | 2026-02-19 |
| Insider trade | 4 | 2026-02-20 | 2026-02-19 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| Annual insider summary | 5 | 2026-02-13 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13D/A | - | 2026-02-13 | - |
| SCHEDULE 13G | - | 2026-02-05 | - |
| SCHEDULE 13G | - | 2026-01-30 | - |
| Insider trade | 4 | 2026-01-12 | 2026-01-08 |
| New insider ownership | 3 | 2026-01-12 | 2026-01-08 |
| Major company event | 8-K | 2025-12-05 | 2025-12-01 |
| Insider trade | 4 | 2025-12-03 | 2025-12-02 |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| S-3ASR | - | 2025-11-13 | - |
| Quarterly report | 10-Q | 2025-11-13 | 2025-09-30 |
| Major company event | 8-K | 2025-11-13 | 2025-11-13 |
| SCHEDULE 13G | - | 2025-10-17 | - |
| Insider sale notice | 144 | 2025-10-07 | - |
| Insider sale notice | 144 | 2025-10-03 | - |
| Insider sale notice | 144 | 2025-08-27 | - |
| Major company event | 8-K | 2025-08-20 | 2025-08-14 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13D/A | - | 2025-08-11 | - |
| Employee stock plan | S-8 | 2025-08-07 | - |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |